360 related articles for article (PubMed ID: 26049075)
1. Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.
Diop M; Auberval N; Viciglio A; Langlois A; Bietiger W; Mura C; Peronet C; Bekel A; Julien David D; Zhao M; Pinget M; Jeandidier N; Vauthier C; Marchioni E; Frere Y; Sigrist S
Int J Pharm; 2015 Aug; 491(1-2):402-8. PubMed ID: 26049075
[TBL] [Abstract][Full Text] [Related]
2. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
4. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
5. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
6. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
8. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Boselli C; Caramella C
AAPS PharmSciTech; 2010 Mar; 11(1):362-71. PubMed ID: 20232266
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
11. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.
Sonaje K; Chen YJ; Chen HL; Wey SP; Juang JH; Nguyen HN; Hsu CW; Lin KJ; Sung HW
Biomaterials; 2010 Apr; 31(12):3384-94. PubMed ID: 20149435
[TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
14. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
Sonaje K; Lin YH; Juang JH; Wey SP; Chen CT; Sung HW
Biomaterials; 2009 Apr; 30(12):2329-39. PubMed ID: 19176244
[TBL] [Abstract][Full Text] [Related]
16. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
17. Thiomer nanoparticles: stabilization via covalent cross-linking.
Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
[TBL] [Abstract][Full Text] [Related]
18. Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing.
Jose S; Fangueiro JF; Smitha J; Cinu TA; Chacko AJ; Premaletha K; Souto EB
Colloids Surf B Biointerfaces; 2012 Apr; 92():175-9. PubMed ID: 22221459
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
20. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]